Healthcare & Pharmaceuticals Industry Press Releases

Published on February 2, 2023 - 13:45 GMT

International Myeloma Foundation (IMF) Returns to In-Person Patient and Family Seminars in 2023, Announces Boca Raton Event

BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that this year’s first Patient and Family Seminar is taking place in-person and virtually on March 17–18, 2023, in Boca Raton, Florida. The event …

Distribution channels:

Published on February 2, 2023 - 13:34 GMT

Global Shockwave Therapy Market Is Expected to Reach $2,269.63 Million by 2031: Says AMR

Portland,OR, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Shockwave Therapy Market was estimated for $1,171.19 million in 2021 and is estimated to reach $2,269.63 million by 2031, exhibiting a …

Distribution channels: Book Publishing Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 13:30 GMT

BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm

HENDERSON, NV, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into a non-binding letter of intent (“LOI”) dated February 01, 2023 with Canadian Company–Work In Motion pursuant …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry

Published on February 2, 2023 - 13:30 GMT

POINT Biopharma to Participate in Upcoming Investor Conferences

INDIANAPOLIS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced management …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 13:30 GMT

Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference

BOSTON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2023 - 13:30 GMT

Ehave Provides Progress Update on its HPPD Study with University of Melbourne

MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, is pleased to announce it has completed the first phase of its …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...

Published on February 2, 2023 - 13:30 GMT

Integer to Exhibit at 2023 MD&M West Expo, February 7 – 9

PLANO, Texas, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in exhibiting at the MD&M West …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on February 2, 2023 - 13:20 GMT

As of 2027, the HPV Testing and Pap Test Market is expected to reach US$ 9.2 billion at a CAGR of 13.2% - Exclusive Report by ...

Chicago, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to the new market research report published by MarketsandMarkets, "HPV Testing and Pap Test Market Size, Growth by Test Type (HPV Testing (Follow-Up HPV Testing, Co- Testing, Primary HPV Testing), …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on February 2, 2023 - 13:02 GMT

Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for ...

SOUTH SAN FRANCISCO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on February 2, 2023 - 13:01 GMT

Promex Further Extends Die-Bonding Proficiencies

SANTA CLARA, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Promex Industries, a Silicon Valley–based provider of advanced design, packaging, and microelectronics assembly services, today announced the next key addition to its die-bonding service capabilities: …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on February 2, 2023 - 13:01 GMT

Gradalis to Present at the 2023 BIO CEO & Investor Conference

DALLAS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Gradalis, Inc., a privately held, late-stage clinical biotechnology company developing a personalized immunotherapy called Vigil® for patients with ovarian and other cancer tumor types, today announced that Steven …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...